284 related articles for article (PubMed ID: 37463049)
1. The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.
McMyn NF; Varriale J; Fray EJ; Zitzmann C; MacLeod H; Lai J; Singhal A; Moskovljevic M; Garcia MA; Lopez BM; Hariharan V; Rhodehouse K; Lynn K; Tebas P; Mounzer K; Montaner LJ; Benko E; Kovacs C; Hoh R; Simonetti FR; Laird GM; Deeks SG; Ribeiro RM; Perelson AS; Siliciano RF; Siliciano JM
J Clin Invest; 2023 Sep; 133(17):. PubMed ID: 37463049
[TBL] [Abstract][Full Text] [Related]
2. Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy.
White JA; Simonetti FR; Beg S; McMyn NF; Dai W; Bachmann N; Lai J; Ford WC; Bunch C; Jones JL; Ribeiro RM; Perelson AS; Siliciano JD; Siliciano RF
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35110411
[TBL] [Abstract][Full Text] [Related]
3. Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.
Katusiime MG; Halvas EK; Wright I; Joseph K; Bale MJ; Kirby-McCullough B; Engelbrecht S; Shao W; Hu WS; Cotton MF; Mellors JW; Kearney MF; van Zyl GU
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776265
[TBL] [Abstract][Full Text] [Related]
4. Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNA.
Gaebler C; Falcinelli SD; Stoffel E; Read J; Murtagh R; Oliveira TY; Ramos V; Lorenzi JCC; Kirchherr J; James KS; Allard B; Baker C; Kuruc JD; Caskey M; Archin NM; Siliciano RF; Margolis DM; Nussenzweig MC
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361426
[TBL] [Abstract][Full Text] [Related]
5. Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir.
Kumar MR; Fray EJ; Bender AM; Zitzmann C; Ribeiro RM; Perelson AS; Barouch DH; Siliciano JD; Siliciano RF
Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2313209120. PubMed ID: 37844236
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.
Vibholm LK; Lorenzi JCC; Pai JA; Cohen YZ; Oliveira TY; Barton JP; Garcia Noceda M; Lu CL; Ablanedo-Terrazas Y; Del Rio Estrada PM; Reyes-Teran G; Tolstrup M; Denton PW; Damsgaard T; Søgaard OS; Nussenzweig MC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700598
[TBL] [Abstract][Full Text] [Related]
7. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.
Shahid A; MacLennan S; Jones BR; Sudderuddin H; Dang Z; Cobarrubias K; Duncan MC; Kinloch NN; Dapp MJ; Archin NM; Fischl MA; Ofotokun I; Adimora A; Gange S; Aouizerat B; Kuniholm MH; Kassaye S; Mullins JI; Goldstein H; Joy JB; Anastos K; Brumme ZL;
J Virol; 2024 Feb; 98(2):e0165523. PubMed ID: 38214547
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing.
Cho A; Gaebler C; Olveira T; Ramos V; Saad M; Lorenzi JCC; Gazumyan A; Moir S; Caskey M; Chun TW; Nussenzweig MC
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042816
[TBL] [Abstract][Full Text] [Related]
9. Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.
Rainwater-Lovett K; Ziemniak C; Watson D; Luzuriaga K; Siberry G; Petru A; Chen Y; Uprety P; McManus M; Ho YC; Lamers SL; Persaud D
PLoS One; 2017; 12(2):e0170548. PubMed ID: 28178277
[TBL] [Abstract][Full Text] [Related]
10. CD161
Li X; Liu Z; Li Q; Hu R; Zhao L; Yang Y; Zhao J; Huang Z; Gao H; Li L; Cai W; Deng K
mBio; 2019 Oct; 10(5):. PubMed ID: 31594817
[TBL] [Abstract][Full Text] [Related]
11. Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana.
Koofhethile CK; Moyo S; Kotokwe KP; Chang C; Mokgethi P; Muchoba L; Mokgweetsi S; Makhema J; Lockman S; Gaseitsiwe S; de Oliveira T; Essex M; Shapiro R; Kanki P; Novitsky V
AIDS Res Hum Retroviruses; 2021 Jan; 37(1):16-23. PubMed ID: 32935556
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies.
Kreider EF; Bar KJ
Curr HIV/AIDS Rep; 2022 Jun; 19(3):194-206. PubMed ID: 35404007
[TBL] [Abstract][Full Text] [Related]
13. Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients.
Nicolas A; Migraine J; Dutrieux J; Salmona M; Tauzin A; Hachiya A; Estaquier J; Molina JM; Clavel F; Hance AJ; Mammano F
Microbiol Spectr; 2022 Aug; 10(4):e0078422. PubMed ID: 35770985
[TBL] [Abstract][Full Text] [Related]
14. Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.
Abreu CM; Veenhuis RT; Avalos CR; Graham S; Parrilla DR; Ferreira EA; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Mac Gabhann F; O'Connor SL; Gama L; Clements JE
mBio; 2019 Aug; 10(4):. PubMed ID: 31431552
[TBL] [Abstract][Full Text] [Related]
15. The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
Joseph SB; Abrahams MR; Moeser M; Tyers L; Archin NM; Council OD; Sondgeroth A; Spielvogel E; Emery A; Zhou S; Doolabh D; Ismail SD; Karim SA; Margolis DM; Pond SK; Garrett N; Swanstrom R; Williamson C
PLoS Pathog; 2024 Feb; 20(2):e1011974. PubMed ID: 38422171
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells.
Soriano-Sarabia N; Bateson RE; Dahl NP; Crooks AM; Kuruc JD; Margolis DM; Archin NM
J Virol; 2014 Dec; 88(24):14070-7. PubMed ID: 25253353
[TBL] [Abstract][Full Text] [Related]
17. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
[TBL] [Abstract][Full Text] [Related]
18. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
[TBL] [Abstract][Full Text] [Related]
19. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
[TBL] [Abstract][Full Text] [Related]
20. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.
Gandhi RT; Cyktor JC; Bosch RJ; Mar H; Laird GM; Martin A; Collier AC; Riddler SA; Macatangay BJ; Rinaldo CR; Eron JJ; Siliciano JD; McMahon DK; Mellors JW;
J Infect Dis; 2021 Feb; 223(2):225-233. PubMed ID: 32823274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
